跳至主要内容
临床试验/ACTRN12615000171516
ACTRN12615000171516进行中(未招募)未知

Pyronaridine-artesunate efficacy for the treatment of uncomplicated falciparum malaria in Cambodia

World Health Organization0 个研究点目标入组 145 人开始时间: 2015年2月20日最近更新:
适应症

试验速览

阶段
未知
状态
进行中(未招募)
入组人数
145

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Treatment

入排标准

年龄范围
10 Years 至 65 Years(—)
性别
All

入选标准

  • Adults and children with body weight of 20 kg or above
  • - Symptomatic of malaria infection, i.e. history of fever within 24 hours and/or presence of fever 37.5 degree celcius or above
  • - Microscopic confirmation of asexual stages of P. falciparum (P. falciparum and mixed infection in Pailin only)
  • - Capability of taking an oral medication

排除标准

  • - Pregnancy or lactation (urine test for beta HCG to be performed on any woman of child bearing age, that is 18 to 45 years old)
  • - Female aged 12-18y
  • - Parasitemia less than 150 000/microlitre).
  • - Signs or symptoms indicative of severe malaria:
  • - Impaired consciousness (Blantyre Coma Score less than 5)
  • - Severe anaemia (Hct less than15%)

研究者

相似试验